Hannah Alison L. is a director of Neogenomics Inc.
Person profile
Roles
Neogenomics
Director
Rigel Pharmaceuticals
Director
Address
Fort Myers, Florida
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
NEOGENOMICS INC
14 Aug 23
4
RIGEL PHARMACEUTICALS INC
12 Jul 23
4
CytomX Therapeutics, Inc.
21 Jul 22
4
NEOGENOMICS INC
14 Jun 22
4
RIGEL PHARMACEUTICALS INC
23 May 22
4
CytomX Therapeutics, Inc.
4 Feb 22
4
CytomX Therapeutics, Inc.
26 Oct 21
4
NEOGENOMICS INC
5 Jun 21
4
RIGEL PHARMACEUTICALS INC
21 May 21
4
RIGEL PHARMACEUTICALS INC
18 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Aug 23 | NEO Neogenomics | RSU Common Stock | Grant | Acquire A | No | No | 0 | 11,336 | 0.00 | 11,336 |
10 Aug 23 | NEO Neogenomics | Stock Option Common Stock | Grant | Acquire A | No | No | 14.82 | 8,353 | 123.79 k | 8,353 |
26 May 23 | RIGL Rigel Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 56,250 |
26 May 23 | RIGL Rigel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 30,000 | 39.60 k | 30,000 |